Published in Pathology on October 01, 2004
An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J Cutan Pathol (2012) 2.31
The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms. PLoS One (2009) 1.09
Atypical or typical pagetoid cell: a subtle clue to differentiate a melanoma from a melanocytic nevus. Dermatol Pract Concept (2013) 0.95
Spitz nevi and other Spitzoid lesions part II. Natural history and management. J Am Acad Dermatol (2011) 0.87
Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults. J Natl Compr Canc Netw (2013) 0.81
Clinical Application of the Unifying Concept of Cutaneous Melanoma. Chonnam Med J (2017) 0.80
The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists. Medicine (Baltimore) (2016) 0.80
Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP). Am J Surg Pathol (2013) 0.78
Pigmented epithelioid melanocytoma in a child: unusual clinical presentation. Iran J Pediatr (2013) 0.75
Signature nevi: individuals with multiple melanocytic nevi commonly have similar clinical and histologic patterns. Dermatol Pract Concept (2011) 0.75
Controversies in the diagnosis and treatment of early cutaneous melanoma. J Med Life (2015) 0.75
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell (2010) 12.50
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol (2011) 2.38
An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J Cutan Pathol (2012) 2.31
Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol (2006) 2.13
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3. J Clin Invest (2013) 2.11
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol (2004) 1.90
Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol (2007) 1.89
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol (2013) 1.88
Stem cells with neural crest characteristics derived from the bulge region of cultured human hair follicles. J Invest Dermatol (2009) 1.85
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest (2014) 1.81
Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol Cell (2012) 1.63
Mining FDA drug labels using an unsupervised learning technique--topic modeling. BMC Bioinformatics (2011) 1.53
Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov (2013) 1.52
Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci (2010) 1.48
Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res (2011) 1.47
Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol (2005) 1.46
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma. Cell Rep (2013) 1.43
MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol (2009) 1.38
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res (2007) 1.37
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am J Pathol (2009) 1.31
Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells (2006) 1.27
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol (2005) 1.26
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res (2005) 1.24
A structural approach for finding functional modules from large biological networks. BMC Bioinformatics (2008) 1.22
Investigating drug repositioning opportunities in FDA drug labels through topic modeling. BMC Bioinformatics (2012) 1.22
Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort. Eur J Cancer (2011) 1.21
MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol (2011) 1.17
Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation. Mod Pathol (2006) 1.16
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg (2009) 1.14
miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. Am J Pathol (2012) 1.13
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol (2005) 1.11
Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer (2004) 1.09
Automatic delineation of malignancy in histopathological head and neck slides. BMC Bioinformatics (2007) 1.09
Reciprocal regulation of MelCAM and AKT in human melanoma. Oncogene (2003) 1.08
Functional erythropoietin autocrine loop in melanoma. Am J Pathol (2005) 1.06
MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Methods Mol Biol (2011) 1.06
Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol (2013) 1.05
Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest (2012) 1.04
IL-8 and cathepsin B as melanoma serum biomarkers. Int J Mol Sci (2011) 1.00
New insights into the genetics of in vivo induction of maternal haploids, the backbone of doubled haploid technology in maize. Genetics (2011) 0.99
Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Am J Surg Pathol (2007) 0.99
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol (2014) 0.99
Exo70 generates membrane curvature for morphogenesis and cell migration. Dev Cell (2013) 0.98
Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature. Pigment Cell Melanoma Res (2012) 0.95
Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells. Cancer Lett (2004) 0.95
In silico drug repositioning: what we need to know. Drug Discov Today (2012) 0.93
Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy. Ann Surg Oncol (2013) 0.93
Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol (2011) 0.93
Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One (2013) 0.93
A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients. PLoS One (2013) 0.93
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest (2016) 0.93
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma. Am J Surg Pathol (2011) 0.92
Screening level ecological risk assessment for phenols in surface water of the Taihu Lake. Chemosphere (2010) 0.92
Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol (2004) 0.92
Fertilization and uniparental chromosome elimination during crosses with maize haploid inducers. Plant Physiol (2013) 0.91
Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker. Proc Natl Acad Sci U S A (2009) 0.91
Snail1 mediates hypoxia-induced melanoma progression. Am J Pathol (2011) 0.90
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells. Am J Pathol (2009) 0.89
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res (2014) 0.89
The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro. J Dermatol Sci (2012) 0.88
Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci (2012) 0.88
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol (2006) 0.88
Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy (2015) 0.88
Nuclear orphan receptor TR3/Nur77 mediates melanoma cell apoptosis. Cancer Biol Ther (2007) 0.88
Mining hidden knowledge for drug safety assessment: topic modeling of LiverTox as a case study. BMC Bioinformatics (2014) 0.88
Nonpseudomonal ecthyma gangrenosum associated with methicillin-resistant staphylococcus aureus infection: a case report and review of the literature. Cutis (2012) 0.87
Circulating melanoma cells as a predictive biomarker. J Invest Dermatol (2013) 0.87
Local immune response predicts survival in patients with thick (t4) melanomas. Ann Surg Oncol (2013) 0.86
Selective chemical labelling of 5-formylcytosine in DNA by fluorescent dyes. Chemistry (2013) 0.86
Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells. Melanoma Res (2006) 0.86
Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107. Proc Natl Acad Sci U S A (2005) 0.86
Eltrombopag-associated hyperpigmentation. JAMA Dermatol (2013) 0.86
Selective detection of 5-formyl-2'-deoxycytidine in DNA using a fluorogenic hydroxylamine reagent. Org Lett (2013) 0.86
atBioNet--an integrated network analysis tool for genomics and biomarker discovery. BMC Genomics (2012) 0.85
Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med (2010) 0.84
Morphological and molecular evidences for DNA introgression in haploid induction via a high oil inducer CAUHOI in maize. Planta (2009) 0.84
Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol (2013) 0.84
MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma. Int J Surg Pathol (2011) 0.84
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib. Clin Cancer Res (2013) 0.84
ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis. Thromb Res (2011) 0.84
MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations. Am J Dermatopathol (2013) 0.83
Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Arch Pathol Lab Med (2003) 0.82
Leukemia labialis: a rare presentation of leukemia cutis limited to the lips. J Am Acad Dermatol (2012) 0.82
Constructing a robust protein-protein interaction network by integrating multiple public databases. BMC Bioinformatics (2011) 0.82
Isolation and culture of neural crest stem cells from human hair follicles. J Vis Exp (2013) 0.82
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma. Mol Cell Biol (2013) 0.81
A systems approach for analysis of high content screening assay data with topic modeling. BMC Bioinformatics (2013) 0.81
A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure. Int J Artif Organs (2014) 0.81
Major response to everolimus in melanoma with acquired imatinib resistance. J Clin Oncol (2011) 0.81
Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis. Am J Dermatopathol (2013) 0.80
A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway. Int J Mol Sci (2012) 0.80
Synthesis and spectroscopic properties of fluorescent 5-benzimidazolyl-2'-deoxyuridines 5-fdU probes obtained from o-phenylenediamine derivatives. Org Biomol Chem (2013) 0.80
Lentiviral-Mediated shRNA Silencing of PDE4D Gene Inhibits Platelet-Derived Growth Factor-Induced Proliferation and Migration of Rat Aortic Smooth Muscle Cells. Stroke Res Treat (2011) 0.79
Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol (2007) 0.79
Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP). Am J Surg Pathol (2013) 0.78
Association between 1425G/A SNP in PRKCH and ischemic stroke among Chinese and Japanese populations: a meta-analysis including 3686 cases and 4589 controls. Neurosci Lett (2011) 0.78
Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway. Cancer Biol Ther (2011) 0.78
Transient myeloproliferative disorder causing a vesiculopustular eruption in a phenotypically normal neonate. Pediatr Dermatol (2004) 0.77